Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder

Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors pr...

Full description

Saved in:
Bibliographic Details
Published in:International journal of dermatology 2004-12, Vol.43 (12), p.922-924
Main Authors: Martin, Lucy K., Romanelli, Paolo, Ahn, Yeon Soong, Kirsner, Robert S.
Format: Article
Language:English
Subjects:
Biological and medical sciences
Dermatology
Female
Humans
Leg Dermatoses - drug therapy
Leg Dermatoses - etiology
Mastocytosis, Cutaneous - drug therapy
Mastocytosis, Cutaneous - etiology
Medical sciences
Middle Aged
Polycythemia Vera - complications
PUVA Therapy
Skin Diseases, Vascular - drug therapy
Skin Diseases, Vascular - etiology
Telangiectasis - drug therapy
Telangiectasis - etiology
Thrombocytosis - complications
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.
ISSN:0011-9059
1365-4632
DOI:10.1111/j.1365-4632.2004.02249.x